Author

Mansilla E

C

Biography

Tissue Engineering, Regenerative Medicine and Cell Therapies Laboratory, CUCAIBA, Ministry of Health, Calle 129 e/ 51 y 53- 1925- El Dique-Partido de Ensenada, Province of Buenos Aires, Argentinaduardo Mansilla is at Regenerative Medicine And Cell Therapies Laboratory in La Plata, Argentina. His clinical research consists of co-authoring 9 peer-reviewed articles in the past 15 years
Title
Cited by
Year
Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence …
E Mansilla, GH Marın, H Drago, F Sturla, E Salas, C Gardiner, S Bossi, ...Transplantation proceedings 38 (3), 967-969, 2006200
251
2006
Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries
E Mansilla, GH Marin, F Sturla, HE Drago, MA Gil, E Salas, MC Gardiner, ...Transplantation proceedings 37 (1), 292-294, 2005200
206
2005
Feasibility investigation of allogeneic endometrial regenerative cells
Z Zhong, AN Patel, TE Ichim, NH Riordan, H Wang, WP Min, EJ Woods, ...Journal of Translational Medicine 7, 1-7, 2009200
158
2009
Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?
E Mansilla, V Diaz Aquino, D Zambon, GH Marin, K Mártire, G Roque, ...Stem cells international 2011, 2011201
62
2011
The next generation of burns treatment: intelligent films and matrix, controlled enzymatic debridement, and adult stem cells
H Drago, GH Marín, F Sturla, G Roque, K Mártire, VD Aquino, ...Transplantation Proceedings 42 (1), 345-349, 2010201
57
2010
Outstanding survival and regeneration process by the use of intelligent acellular dermal matrices and mesenchymal stem cells in a burn pig model
E Mansilla, R Spretz, G Larsen, L Nuñez, H Drago, F Sturla, GH Marin, ...Transplantation proceedings 42 (10), 4275-4278, 2010201
52
2010
Cadaveric bone marrow mesenchymal stem cells: first experience treating a patient with large severe burns
E Mansilla, GH Marín, M Berges, S Scafatti, J Rivas, A Núñez, ...Burns & Trauma 3, 2015201
50
2015
New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles
N Mezzaroba, S Zorzet, E Secco, S Biffi, C Tripodo, M Calvaruso, ...PloS one 8 (9), e74216, 2013201
40
2013
Use of human cadaveric mesenchymal stem cells for cell therapy of a chronic radiation-induced skin lesion: A case report
M Portas, E Mansilla, H Drago, D Dubner, A Radl, A Coppola, ...Radiation protection dosimetry 171 (1), 99-106, 2016201
28
2016
Enhanced singlet oxygen production by photodynamic therapy and a novel method for its intracellular measurement
SLP Luengas, GH Marin, K Aviles, RC Acuna, G Roque, FR Nieto, ...Cancer Biotherapy and Radiopharmaceuticals 29 (10), 435-443, 2014201
25
2014
Apoptosis induced by Magnolia Grandiflora extract in chlorambucil-resistant B-chronic lymphocytic leukemia cells
GH Marin, E MansillaJournal of cancer research and therapeutics 6 (4), 463-465, 2010201
24
2010
The lysosomotropic agent, hydroxychloroquine, delivered in a biodegradable nanoparticle system, overcomes drug resistance of B-chronic lymphocytic leukemia cells in vitro
E Mansilla, GH Marin, L Nunez, H Drago, F Sturla, C Mertz, L Rivera, ...Cancer Biotherapy and Radiopharmaceuticals 25 (1), 97-103, 2010201
24
2010
Time and regeneration in burns treatment: heading into the first worldwide clinical trial with cadaveric mesenchymal stem cells
E Mansilla, VD Aquino, G Roque, JM Tau, A MaceiraBurns 3 (38), 450-452, 2012201
19
2012
Matrix superhighways configurations: new concepts for complex organ regeneration
E Mansilla, H Drago, F Sturla, S Bossi, E Salas, GH Marín, R Ibar, ...Transplantation proceedings 39 (7), 2431-2433, 2007200
18
2007
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles
S Capolla, N Mezzaroba, S Zorzet, C Tripodo, R Mendoza-Maldonado, ...Nano Research 9, 537-548, 2016201
18
2016
Increased prevalence of carotid and femoral atherosclerosis in renal transplant recipients
F Cofan, I Nuñez, R Gilabert, D Zambon, E Ros, M Cofan, S Muray, ...Transplantation proceedings 1 (33), 1254-1256, 2001200
14
2001
A rat treated with mesenchymal stem cells lives to 44 months of age
E Mansilla, G Roque, YE Sosa, A Tarditti, RG GoyaRejuvenation Research 19 (4), 318-321, 2016201
13
2016
Racemized and isomerized proteins in aging rat teeth and eye lens
RA Warmack, E Mansilla, RG Goya, SG ClarkeRejuvenation Research 19 (4), 309-317, 2016201
12
2016
Mesenchymal stem cells, could they be the link between tolerance and regeneration?
E Mansilla, H Drago, GH Marin, F Sturla, R Ibar, C SorattiBurns: Journal of the International Society for Burn Injuries 33 (2), 137-138, 2007200
12
2007
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma
G H Marin, E Mansilla, N Mezzaroba, S Zorzet, L Núñez, G Larsen, ...Current clinical pharmacology 5 (4), 246-250, 2010201
11
2010

Referred From: https://scholar.google.es/citations?user=Djo5npwAAAAJ&hl=es

Cited by
Citations 1183
h-index 15
i10-index 23
Open Access Journals